47 results on '"Decker, Roy H."'
Search Results
2. Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model
3. Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy
4. Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs
5. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques
6. A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)
7. A Blinded, Prospective Study of Error Detection During Physician Chart Rounds in Radiation Oncology
8. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma
9. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis
10. Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy
11. High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors
12. Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis
13. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall
14. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer
15. Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
16. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
17. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy
18. Who benefits from chemoradiation in stage III–IVA endometrial cancer? An analysis of the National Cancer Data Base
19. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer
20. Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases
21. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy
22. Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC
23. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non–Small-Cell Lung Cancer at High Risk for Brain Metastases
24. Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database
25. ACR Appropriateness Criteria Nonsurgical Treatment for Non–Small-Cell Lung Cancer: Poor Performance Status or Palliative Intent
26. Patterns of Care and Outcomes Associated With Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Older Patients With Head-and-Neck Cancer
27. A novel modified dynamic conformal arc technique for treatment of peripheral lung tumors using stereotactic body radiation therapy
28. A significant decrease in rectal volume and diameter during prostate IMRT
29. The Impact of Pretreatment Prostate Volume on Severe Acute Genitourinary Toxicity in Prostate Cancer Patients Treated With Intensity-Modulated Radiation Therapy
30. A Prognostic Index for Predicting Lymph Node Metastasis in Minor Salivary Gland Cancer
31. Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ
32. Whole Pelvic Radiotherapy Versus Prostate Only Radiotherapy in the Management of Locally Advanced or Aggressive Prostate Adenocarcinoma
33. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
34. Postoperative Radiation Therapy for Non-Small Cell Lung Cancer
35. Capítulo 5 - Tratamiento con intención curativa del carcinoma pulmonar de células no pequeñas en estadio III
36. Chapter 5 - Curative Intent Treatment of Stage III Non–Small Cell Lung Cancer
37. Prophylactic Cranial Irradiation Versus Surveillance: Physician Bias and Patient-centered Decision-making
38. A reply to “Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC”
39. SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time
40. OA35 - Rates of Invasive Carcinoma Following Resection in Patients with Carcinoma-in-situ on Biopsy
41. List of Contributors
42. (P085) Trends in Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer
43. (S027) Hypofractionated Radiotherapy Is associated With Improved Overall Survival Among Patients With Early-Stage Glottic Cancer
44. Taking “the Game” Out of The Match: A Simple Proposal
45. Stereotactic Radiotherapy in the Treatment of Primary Bronchial Carcinoid Tumor
46. Colaboradores
47. Surgery versus implant for early prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.